An Act to Amend Title 16 of the Delaware Code Relating to Naloxone and Other Opioid Antagonists.
It became law on Nov 2, 2022.
- Stage
- Became law
- Started in
- Senate
- Sponsors
- +25
- Latest action
- Nov 2, 2022
What it does
An opioid antagonist is a medication approved by the United States Food and Drug Administration (FDA) for emergency reversal of a known or suspected opioid overdose. Currently, naloxone is the only FDA-approved opioid antagonist, however, the FDA is expected to approve at least 1 new, more powerful opioid antagonist in 2022. The current naloxone program allows public safety personnel and trained lay people to receive and administer naloxone to individuals suspected of experiencing an opioid overdose. This Act allows the Department of Health and Social Services to expand the current program to include additional opioid antagonists. This Act also makes technical corrections to reflect that…
Where it stands
This bill passed and is now law.
Introduced (Done)
Committee (Done)
Floor (Done)
Law (Done)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
- Darius Brown
- David Bentz
- Sarah McBride
- Stephanie Hansen
- Brian Pettyjohn
- Bruce C. Ennis
- Bryan Townsend
- Bryant Richardson
- Colin Bonini
- Dave Lawson
- Dave Sokola
- Dave Wilson
- Debra Heffernan
- Eric Morrison
- Ernesto B. Lopez
- Gerald Hocker
- Jack Walsh
- John A. Kowalko
- Kendra Johnson
- Kyle Gay
- Laura Sturgeon
- Marie Pinkney
- Mike Smith
- Nicole Poore
- Paul Baumbach
- Ruth Briggs King
- Spiros Mantzavinos
- Tizzy Lockman
- Trey Paradee
In the news
Reporting that may mention this subject. Possible matches are labeled.
Loading coverage…
Where it goes next
It is law in Delaware. What happens now is up to the agency that carries it out, the courts, and the place itself.